Medtronic plc MDT has received a Health Canada license to use the Hugo robotic-assisted surgery system.
- According to a news release, those procedures make up about half of all robotic surgery procedures performed today.
- In May, Hugo garnered FDA investigational device exemption (announced in Q4 FY21 earnings conference call), followed by the first clinical procedure with Hugo in Chile, which Medtronic announced in May.
- The platform offers a modular, multi-quadrant platform designed for a broad range of surgical procedures with wristed instruments, 3D visualization, and surgical video capture option in Touch Surgery Enterprise.
- Medtronic announced in October that it received CE mark approval for Hugo.
- Price Action: MDT shares are up 2.60% at $113.11 during the market session on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in